Iain Leslie Campbell Chapple

Title: Iain Leslie Campbell Chapple: Innovator in Periodontitis Diagnostics

Introduction

Iain Leslie Campbell Chapple is a notable inventor based in Birmingham, GB. He has made significant contributions to the field of dental diagnostics, particularly in the assessment of periodontitis. His innovative approach has the potential to improve patient outcomes through more accurate diagnoses.

Latest Patents

Iain Chapple holds a patent for a method titled "Diagnostics of mild or advanced periodontitis." This patent describes an in vitro method for assessing whether a human patient suffering from periodontitis has mild or advanced forms of the disease. The method involves measuring the concentrations of specific biomarker proteins in a saliva sample. These proteins include Pyruvate Kinase (PK) and at least one of Matrix metalloproteinase-9 (MMP9), S100 calcium-binding protein A8 (S100A8), and Hemoglobin subunit beta (Hb-beta). The results are compared to a threshold value to determine the severity of the condition.

Career Highlights

Iain Chapple is associated with Koninklijke Philips Corporation N.V., where he applies his expertise in dental diagnostics. His work focuses on developing innovative solutions that enhance the understanding and treatment of periodontal diseases. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in healthcare.

Collaborations

Iain Chapple collaborates with Amir Hussein Rmaile, working together to push the boundaries of dental research and diagnostics. Their combined efforts aim to bring forth new methodologies that can significantly impact patient care.

Conclusion

Iain Leslie Campbell Chapple is a pioneering inventor whose work in periodontitis diagnostics exemplifies the intersection of innovation and healthcare. His contributions are poised to make a lasting impact on the field of dentistry.